Treatment of Upper Respiratory Infections
Most upper respiratory infections are viral and require only symptomatic treatment—antibiotics should NOT be prescribed for the common cold, influenza, COVID-19, or uncomplicated laryngitis. 1, 2, 3
Initial Management: Symptomatic Treatment for All Patients
The cornerstone of URI management is supportive care, regardless of whether antibiotics are eventually needed 2:
- Analgesics/antipyretics: Acetaminophen or NSAIDs (ibuprofen, naproxen) for pain and fever 1, 2
- Saline nasal irrigation: For symptomatic relief of congestion 1, 2
- Intranasal corticosteroids: Reduce mucosal inflammation and may decrease need for antibiotics 1, 2
- Decongestants: Systemic or topical as needed, but limit topical decongestants (oxymetazoline) to 3 days maximum to avoid rebound congestion 2
- Adequate hydration, rest, warm facial packs, sleeping with head elevated 1
Critical pitfall: Avoid over-the-counter cough and cold medications in children under 6 years due to lack of efficacy and potential toxicity 2
When Antibiotics ARE Indicated: Acute Bacterial Sinusitis
Antibiotics are appropriate only when acute bacterial sinusitis is confirmed by one of three clinical patterns 1:
- Persistent symptoms ≥10 days without clinical improvement
- Severe symptoms for ≥3 consecutive days: Fever >39°C, purulent nasal discharge, facial pain
- "Double sickening": Worsening symptoms after initial improvement from a viral URI
First-Line Antibiotic Selection
For uncomplicated maxillary sinusitis (most common type):
- Amoxicillin 500 mg twice daily for mild disease OR 875 mg twice daily for moderate disease 1, 4
- Amoxicillin-clavulanate 875 mg/125 mg twice daily is preferred if recent antibiotic exposure, moderate-to-severe disease, or risk factors present 1
- Duration: 5-10 days, typically until symptom-free for 7 days 1
For penicillin-allergic patients:
- Second-generation cephalosporins: Cefuroxime-axetil 1, 5
- Third-generation cephalosporins: Cefpodoxime-proxetil or cefdinir (NOT cefixime, which lacks pneumococcal coverage) 1, 5
- For severe beta-lactam allergy: Levofloxacin 500 mg once daily for 10-14 days 1
Critical pitfall: Azithromycin and other macrolides should NOT be used due to 20-25% resistance rates 1
Pediatric Dosing
- Standard therapy: Amoxicillin 45 mg/kg/day in 2 divided doses 1
- High-dose therapy (for areas with resistant S. pneumoniae or risk factors): Amoxicillin 80-90 mg/kg/day in 2 divided doses 1
- Amoxicillin-clavulanate: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses for children <2 years, daycare attendance, or recent antibiotic use 1
Treatment Failure Protocol
Reassess at 3-5 days (72 hours in pediatrics) if no improvement 1:
- Switch to high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate, max 2 g every 12 hours) 1
- Alternative: Respiratory fluoroquinolones (levofloxacin 500-750 mg once daily or moxifloxacin) for treatment failures or complicated sinusitis 1
- Consider: Complications, alternative diagnosis, or ENT referral if symptoms worsen 1
Complicated Sinusitis (Frontal, Ethmoidal, Sphenoidal)
Reserve fluoroquinolones (levofloxacin or moxifloxacin) for these anatomic locations due to potential for serious complications 1, 5
Adjunctive Therapies for Bacterial Sinusitis
- Intranasal corticosteroids: Recommended as adjunct to antibiotics in acute and chronic sinusitis 1
- Short-term oral corticosteroids: May be reasonable for marked mucosal edema or failure to respond to initial treatment (typically 5 days) 1
Critical pitfall: Corticosteroids should never be used as monotherapy—antibiotics are necessary to treat the underlying bacterial infection 1
Watchful Waiting Option
For adults with uncomplicated acute bacterial sinusitis, watchful waiting without immediate antibiotics is appropriate when follow-up can be assured, with antibiotics started if no improvement by 7 days or worsening at any time 1
Common Pitfalls to Avoid
- Do NOT prescribe antibiotics for common cold, influenza, COVID-19, or laryngitis 2, 3
- Do NOT use cefixime for respiratory infections—it lacks activity against pneumococci with decreased penicillin susceptibility 5, 2
- Do NOT use fluoroquinolones routinely—reserve for treatment failures, complicated sinusitis, or multi-drug resistant organisms to prevent resistance 1
- Ensure adequate treatment duration (minimum 5 days, typically 7-10 days) to prevent relapse 1
- Reassess patients who fail to improve within 3-5 days to avoid treatment failure 1